TABLE 2.
Clinical characteristics, laboratory features, and use of resources: meta-analyses.
| Variables | Studies (*), n/N | Cases/Total, n/N | Pooled proportion [95% CI] from meta-analyses |
| Age, years (median, IQR) | 23/23 | 592/592 | 6.5 years (6–7.4 years) |
| Male sex | 23/23 | 355/592 | 0.60 [0.55–0.65] |
| Previously healthy | 16/23 | 250/433 | 0.71 [0.52–0.84] |
| Obesity | 9/23 | 18/179 | 0.11 [0.06–0.20] |
| Close contact | 14/23 | 153/317 | 0.59 [0.39–0.76] |
| Positive PCR | 18/23 | 139/449 | 0.32 [0.22–0.44] |
| Positive serology | 20/23 | 302/472 | 0.74 [0.58–0.86] |
| Fever | 18/23 | 378/423 | 0.99 [0.9–1] |
| Rash | 11/23 | 167/258 | 0.74 [0.51–0.89] |
| Conjunctival injection | 11/23 | 149/264 | 0.67 [0.42–0.86] |
| Kawasaki disease (KD) | 12/23 | 161/273 | 0.61 [0.48–0.79] |
| Shock | 16/23 | 142/331 | 0.52 [0.34–0.70] |